SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Jensen Huangs admission of an affair with a woman suspected of links to Chinese intelligence, and Nvidias board investigation, dominate discussion, with traders focused on possible leadership and national-security fallout. Views are split between concerns about uncertainty and potential export-control scrutiny and buyers who see the scandal as separate from Nvidias business fundamentals; the board has said it has no reason to believe company secrets were compromised.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMDs sharp rebound after a broad AI-chip selloff has traders debating whether buyers are returning or the move is a temporary bounce, amid concerns about data-center spending, regulation and valuations. Some also speculate that controversy around Nvidias CEO could prompt a rotation toward AMD, while bulls point to AMDs strong data-center growth and outlook.

Nasdaq, Inc. is a holding company, which engages in trading, clearing, exchange technology, regulatory, securities listing, information, and public and private company services. It operates through the following segments: Capital Access Platforms, Financial Technology, and Market Services. The Capital Access Platforms segment delivers liquidity, transparency, and integrity to the corporate issuer and investment community by empowering clients to effectively navigate the capital markets, achieve their sustainability goals, and drive governance excellence. The Financial Technology segment offers platforms that improve the liquidity, transparency, and integrity of the global economy by architecting and operating the markets. The Market Services segment includes equity derivative trading and clearing, cash equity trading, fixed income, currency, and commodities trading. The company was founded by Gordon S. Macklin in 1971 and is headquartered in New York, NY.

Nasdaq Inc

Discussion is fragmented, with traders mostly reacting to swings in the broader Nasdaq and tech market, debating whether pullbacks will deepen or rebound. Scattered posts also focus on options activity and Nasdaqs plans for extended-hours trading and tokenized equities, but no single company-specific catalyst clearly dominates.

Vir Biotechnology, Inc. operates as a clinical-stage immunology company that focuses on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases. The firm's technology platforms include antibody, T cell, innate immunity and siRNA, which are designed to stimulate and enhance the immune system by exploiting critical observations of natural immune processes. The company was founded by Robert Taylor Nelsen, Klaus Frueh, Jay Parrish, Lawrence Corey, and Louis Picker in April 7, 2016 and is headquartered in San Francisco, CA.

Vir Biotechnology Inc

Virs Phase 3 ECLIPSE-1 trial met its primary endpoint for its hepatitis delta combination, with traders highlighting the high rate of patients reaching undetectable virus and viewing the results as supportive of the upcoming ECLIPSE-2 and -3 readouts. The reaction is broadly optimistic, though expectations for future approval and commercial success remain uncertain.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

SanDisk is drawing attention amid a sharp memory and AI-hardware selloff, with traders worried that data-center buildouts could slow after election-related pushback and reports of Microsoft pulling back from some neocloud providers. The community is split between expecting further downside as AI demand and memory pricing are reassessed and viewing the drop as an opportunity, citing buybacks, fundamentals, and the upcoming stock split.

GLOBALFOUNDRIES, Inc. provides foundry services and manufactures semiconductors. It offers global shuttle, mask, post-fab and turnkey services. The company was founded on October 7, 2008 and is headquartered in Malta, NY.

GlobalFoundries Inc

GlobalFoundries earnings beat and better-than-expected earnings outlook are drawing attention, but traders are debating why the shares have remained weak amid analyst target cuts. Some see the pullback as a buying opportunity, while others worry about mature-node demand, customer orders, and excess capacity.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

Traders are debating whether reports of an affair involving Nvidia CEO Jensen Huang and a suspected Chinese intelligence asset, along with an independent board probe, pose a real risk to Nvidia and the broader AI-heavy market. Some fear governance or national-security fallout, while others dismiss the story as noise and expect a rebound; Iran headlines and inflation data expectations add to the volatility.

Interactive Brokers Group, Inc. is an investment holding company, which engages in broker or dealer and proprietary trading businesses. It offers custody and service accounts for hedge and mutual funds, exchange-traded funds, registered investment advisors, proprietary trading groups, introducing brokers, and individual investors. The company was founded by Thomas Pechy Peterffy in 1977 and is headquartered in Greenwich, CT.

Interactive Brokers Group Inc - Ordinary Shares - Class A

Interactive Brokers Group Inc 

IBKR is drawing attention after a rally followed by a pullback, with traders debating whether an Elliott Wave correction is underway and whether buyers will return or the decline will deepen. Some remain bullish on the longer-term trend, while others are cautious; traders also note elevated options and off-exchange activity but disagree on what it signals.

The Last Play is Crypto’s 401k.  RETIRE is more than a coin; it’s The Last Play. We are a community dedicated to breaking free from the grind and building true generational wealth. With RETIRE, our mission is simple yet profound: to provide a pathway to retire yourself and secure financial freedom for your bloodline. While others chase hype and trends, we’re focused on creating a legacy that lasts beyond the typical cycle. RETIRE is about making the one move that matters, with a vision for long-term value, freedom, and impact. This isn’t just a meme —it’s a purpose-driven commitment to building a legacy.

The Last Play

A community-led campaign is promoting RETIRE as a Solana memecoin with an on-chain 401(k) and early-retirement theme, alongside calls for weekly DCA and claims of renewed momentum. Supporters point to its active following and price swings, while skeptics warn it is speculative and criticize selling pressure and pump-and-dump risks.

VanEck ETF Trust - VanEck Semiconductor ETF

VanEck Semiconductor ETF

SMH is drawing attention after a sharp semiconductor selloff, with traders questioning whether AI and data-center spending can deliver sufficient returns amid financing concerns and possible regulatory headwinds. The community is split between viewing the decline as an oversold buying opportunity and warning that the AI trade remains under pressure and losses could continue.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Niagen Bioscience (NAGE) Reports Q3 Loss, Lags Revenue Estimates

Niagen Bioscience (NAGE) delivered earnings and revenue surprises of 0.00% and -9.81%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?

Niagen Bioscience, Inc. Reports Third Quarter 2026 Financial Results

Niagen Bioscience, Inc. (NASDAQ:NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced its operational updates and financial results for the third quarter of 2026. Third Quarter 2026 Financial and Business Highlights...

Will Coherus Oncology (CHRS) Report Negative Earnings Next Week? What You Should Know

Coherus Oncology (CHRS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Earnings Preview: Niagen Bioscience (NAGE) Q3 Earnings Expected to Decline

Niagen Bioscience (NAGE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Niagen Bioscience Launches Niagen Plus Liquid At-Home Injections to Support Telehealth Expansion

Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced the launch of the clinician-directed, prescription-only pharmaceutical-grade Niagen At-Home Injection Kit, featuring the Companys...

Niagen Bioscience Makes Skincare a Permanent Tru Niagen Category, Launching Dermatologist-Tested Niagen NanoCloud as a Core Tru Niagen Product

Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced the debut of Tru Niagen Skincare, a permanent new category in the core Tru Niagen line, led by the Niagen Skincare Innovation Lab...

Niagen Bioscience to Report Third Quarter 2026 Financial Results on Wednesday, November 4, 2026

Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announces that it will hold a conference call on Wednesday, November 4, 2026, at 4:30 p.m. ET to discuss its financial results for the third...

Andrew Shao, Ph.D., Senior Vice President of Global Regulatory and Scientific Affairs at Niagen Bioscience, Honored with the 2026 Annette Dickinson Trailblazer Award by Radicle Science and Council for Responsible Nutrition (CRN)

Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announces that Radicle Science and Council for Responsible Nutrition (CRN) honored Andrew Shao, Ph.D., Senior Vice President of Global...

Niagen Bioscience to Present at LD Micro 20th Annual Main Event

Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announces that senior management will participate in the 20th Annual LD Micro Main Event from Monday, October 19 to 21, 2026, in Los Angeles...

Niagen Bioscience Puts 25 Years of NAD+ Science Behind "Don't Get Old. Age Better. a New Campaign for its Niagen Brand Featuring Legendary Surfer Kelly Slater

Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced the launch of Don't Get Old. Age Better., a new brand campaign for its Niagen (patented nicotinamide riboside, or NR) brand and...

• Reported GAAP EPS of -$0.01 down -120.00% YoY
• Reported revenue of $27.19M down -20.01% YoY

Niagen Biosciences Q3 net sales declined 20%; ingredient cost-of-sales rates increased amid lower sales, fixed overhead and pricing concessions; NMN availability increased competition and affected ingredient results.

Niagen Bioscience reported $69.5M in cash and expects resources to cover obligations for at least twelve months; an appeals court reversed Elysiums $9.2M fee award; China sales increased.

Niagen Bioscience, Inc. is a global bioscience company, which engages in acquiring, developing, and commercializing proprietary-based ingredient technologies. It is pioneering research on nicotinamide adenine dinucleotide (NAD+). The company’s patent portfolio includes Nicotinamide Riboside (NR) and other NAD+ precursors, which are commercialized as the flagship ingredient Niagen. It operates through the following segments: Consumer Products, Ingredients, Analytical Reference Standards and Services, and Pharmaceuticals. The Consumer Products segment provides finished dietary supplement products that contain the firm’s proprietary ingredients directly to consumers as well as to distributors. The Ingredients segment supplies ingredients as raw materials to the manufacturers of consumer products. The Analytical Reference Standards and Services segment includes supply of phytochemical reference standards and other research and development services. The Pharmaceuticals segment focuses on the pharmaceutical development of NAD precursor portfolio for potential therapeutic applications in rare diseases. The company was founded by Mark S. Germain and Frank L. Jaksch, Jr. in 1999 and is headquartered in Los Angeles, CA.

Niagen Bioscience Inc.

Bullish Sentiment

Up more than 1% 

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	$2.07
Prev Close	$2.11
Open	$2.06
Dividend Yield	0.00%
50-Day Moving Average	$2.76
Beta	1.50
Avg. Volume	585,229.00
PE Ratio	17.18

52-Week High	$7.28
52-Week Low	$2.04
Market Capitalization	$163.94M
EPS (Annual)	$0.2034
Price to Book	1.97
Revenue Per Employee	$1.11M

Feed

News

Sentiment

Earnings

Fundamentals

Info

NAGE Fundamentals